SUBMISSION DEADLINE: FEBRUARY 2, 2026

SYMPOSIA SUBMISSION GUIDELINES
The whole Symposium must be submitted altogether in a single submission. Submitted symposia should include 3 speakers from 3 different countries and 2 chairs, taking into account gender balance. Each presentation should last 20 minutes for a total of 1 hour of presentation, at the end of the presentations there will be a final discussion time of 15 minutes.
In the text section of your submission, please provide the symposium title, followed by a symposium abstract (maximum 150 words), the title of each lecture, the speaker’s name, surname, and affiliation, and a maximum 250-word abstract for Lecture 1, Lecture 2, and Lecture 3, in this exact order:

Symposium Title
Abstract of Symposium (maximum 150 words)

Lecture 1 Title – Speaker 1 (name, surname, affiliation)
Abstract of Lecture 1 (maximum 250 words)

Lecture 2 Title – Speaker 2 (name, surname, affiliation)
Abstract of Lecture 2 (maximum 250 words)

Lecture 3 Title – Speaker 3 (name, surname, affiliation)
Abstract of Lecture 3 (maximum 250 words)

Learning Objectives: the submission should include two to three learning objectives, each one not exceeding 50 words per statement.

• If the submitting person is involved in the symposium, he/she should also include his/her name in the list.
• The submitting person is responsible for the correct use of the initials and surnames of the people involved in the symposium.
• Organizations should be abbreviated, with capitalization.
• Affiliations: everyone should have an affiliation, at least with a basic entry including the country.

• The title of the symposium should be printed in initial capital letters followed by lowercase.
• Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.
• No graphs, figures, tables, or unusual symbols can be included.
• Place citations to references in square brackets, e.g. [1].
• If there are references after the abstract, there should also be citations to the refs in the abstract, and vice versa.
• Decimal punctuation is with a decimal point (in English), not with a comma.
• Generic (non-proprietary) names should be used for drugs and substances.

If the symposium is selected for presentation, all speakers and chairs are required to register and pay the registration fee. EuGMS is unable to support any participation cost related to submitted symposia, including registration, travel, and accommodation.

SUBMISSION DEADLINE: FEBRUARY 2, 2026

WORKSHOP SUBMISSION GUIDELINES
We cordially invite individuals and groups to submit proposals for interactive and innovative workshops that aim to foster knowledge exchange and skill development in clinical and/or research practice related to geriatric medicine.

• Title of the Workshop
• Context and Purpose
• Workshop Objectives
• Innovative Aspects and Relevance to Clinical or Research Practice
• Proposed Format (e.g., theoretical, educational, hands-on, interactive, simulation-based)
• Number of Speakers/Tutors Involved
• Technical Equipment or Additional Resources Required
• Estimated Duration (up to 75 min)
• Target Audience Size (approximate number of participants)
• Requirement for Pre-Registration
• Potential Sponsors or Funding Sources
• Learning Objectives: the submission should include two to three learning objectives, each one not exceeding 50 words per statement

• If the submitting person is involved in the workshop he/she should also include his/her name in the list.
• The submitting person is responsible for the correct use of the initials and surnames of the people involved in the workshop.
• Organizations should be abbreviated, with capitalization.
• Affiliations: everyone should have an affiliation, at least with a basic entry including the country.

• The title of the workshop should be printed in initial capital letters followed by lowercase.
• Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.
• No graphs, figures, tables, or unusual symbols can be included.
• Place citations to references in square brackets, e.g. [1].
• If there are references after the abstract, there should also be citations to the refs in the abstract, and vice versa.
• Decimal punctuation is with a decimal point (in English), not with a comma.
• Generic (non-proprietary) names should be used for drugs and substances.

If the workshop is selected for presentation, all speakers/tutors are required to register and pay the registration fee. EuGMS is unable to support any participation cost related to submitted symposia, including registration, travel, and accommodation.

Additional Considerations
Please note that if the proposed workshop involves the use of specialized equipment, tools, software, or any other specific materials, the associated costs will not be covered by EuGMS or the Congress organizers. Such expenses must be fully covered by the proposed individuals or institutions.
Proposers are also requested to disclose any partnerships with external companies or organizations that may contribute to the workshop, either through sponsorship or provision of materials and equipment.

SUBMISSION DEADLINE: MARCH 31, 2026

ABSTRACTS SUBMISSION GUIDELINES
Abstracts with more than 250 words will not be accepted.

Authors will be notified of acceptance or rejection of their abstract before the end of the early bird registration deadline. In a follow-up email, detailed information for oral or poster presentation (time allotment, date, time) will be sent by e-mail to the registered presenting Author.

At least one Author of accepted abstracts is required to register and pay the registration fee to ensure the rights for the presentation. EuGMS is unable to support any participation cost related to the submitted abstract, including but not limited to registration, travel, and accommodation. 

• If the submitting person is also one of the authors of the abstract, he/she should also include his/her name in the authors’ list.
• The submitting person is responsible for the correct use of the initials and surnames of the authors.
• Organizations should be abbreviated, with capitalization.
• Affiliations: all authors should have an affiliation, at least with a basic entry including the country.

• Abstracts with more than 250 words will not be accepted.
• The 250-word limit includes any acknowledgements or additional content (e.g., disclosures, funding statements).
• The structure of the abstracts should include: introduction, methods, results, and key conclusions.
• The title of the abstract should be printed in initial capital letters followed by lowercase.
• Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.
• No graphs, figures, tables, or unusual symbols can be included.
• Place citations to references in square brackets, e.g. [1].
• If there are references after the abstract, there should also be citations to the refs in the abstract, and vice versa.
• Decimal punctuation is with a decimal point (in English), not with a comma.
• Generic (nonproprietary) names should be used for drugs and substances.
• Abstracts submitted without specific data will not be considered for oral communication.